Eugene

[email protected]

LATEST

Roche Plans Staff Reductions at California Plant
By

By
Roche’s Genentech is planning staff reductions of more than 200 at its biomanufacturing facility in San Mateo, California. The company reported the changes in an August 10, 2018 WARN (Worker…

Novo Nordisk Acquires Biotech Spinoff for $800 Million to Develop New Forms of Insulin
By

By
Novo Nordisk has acquired Ziylo, a company spun off from the University of Bristol in the UK with a technology platform of synthetic glucose-binding molecules for therapeutic and diagnostic applications,…

FDA Takes Action to Mitigate Shortages of EpiPen
By

By
The US Food and Drug Administration (FDA) is taking action to mitigate shortages of Mylan’s EpiPen (epinephrine), an auto-injector-based epinephrine product for treating adverse allergic reactions, by extending the expiration…

Pfizer in $425-Million mRNA-Based Vaccine Pact with Biopharm Company
By

By
Pfizer has formed a multi-year research and development deal worth up to $425 million with BioNTech AG, a Mainz, Germany-based biopharmaceutical company focused on immunotherapies for treating cancer and infectious…

Kaneka Launches Continuous Mfg Capabilities in Singapore
By

By
Kaneka Corporation, a Tokyo-headquartered chemical manufacturing company, has installed continuous manufacturing equipment for small-molecule pharmaceutical products at Kaneka’s Singapore facility. Kaneka announced the installment in July 2018 and started commercial…

Catalent Completes $133-Million Acquisition of Juniper Pharmaceuticals
By

By
Catalent has completed its previously announced acquisition of Juniper Pharmaceuticals, a Boston, Massachusetts-headquartered specialty pharmaceutical company with contract development and manufacturing services, for $133 million. The companies announced the acquisition…

Astellas Acquires Gene-Therapy Company Quethera
By

By
Astellas Pharma has acquired Quethera, a Cambridge, UK-headquartered gene-therapy company focused on developing treatments for ocular disorders, such as glaucoma, in a deal worth up to £85 million ($108 million).…

Emergent BioSolutions To Acquire Specialty Vaccines Company PaxVax
By

By
Emergent BioSolutions, a Rockville, Maryland-based specialty biopharmaceutical company and contract manufacturer, has agreed to acquire PaxVax, a Redwood City, California-based company focused on specialty vaccines for existing and emerging infectious…

Mylan Forms Strategic Review Committee to Evaluate Options for its Businesses
By

By
Mylan has formed a strategic review committee to evaluate alternatives for its businesses following weak second-quarter performance in its North American segment. Mylan says the profile of the company has…

Perrigo To Separate Prescription Drug Business
By

By
Perrigo has announced plans to separate the company’s prescription pharmaceuticals (Rx) business following a strategic portfolio review. The move follows continuing weak performance in the company’s Rx business, which accounted…